Program & Funding Announcements

Shell’s GameChanger Call for Proposals
Questions about the program or the application submission process can be directed to: Lawrence Lau, Associate Director, Corporate Collaborations,, (213) 821-0947.

Purpose:  The Shell’s GameChanger program has a call for proposal to startup companies focused on the following physical sciences and computer sciences areas. The proposal deadline is Friday, June 30, 2017.


  • Solar fuel innovations
  • Grid of the Future
  • Digitalization: Machine Learning
  • New Routes to Oxygenated Intermediates


  • Safety and Sustainability
  • Novel wells technologies
  • Real-time monitoring, control and data analytics
  • Integrated Geoscience
  • Improved hydrocarbon recovery
  • Environment & Conservation – Water

Applicants: This call seeks to provide seed funding to early stage startups that demonstrate novel approaches to the topics listed.

Proposal Submission Process:  Submission entails a non-confidential proposal including project summary, project overview, technical discussion, proof of concept plan, intellectual property status, commercialization plan, current funding, supporting information (company and personnel information), facilities, and proposed budget.

How to Submit:  Please use the Proposal Template (click here to download) to create your full proposal and submit it through Shell’s GameChanger website:

Amount of funding:  The funding opportunity will be in the range USD 150,000 – 300,000 to progress a “proof of concept” in a phased approach over a period of no more than 12 months. Further development may be supported and or facilitated by Shell depending on the overall outcome of the initial award.


Johnson & Johnson Innovation Labs (JLABS) Quickfire Challenge: Metabolic Disease Innovation
Questions about the program or the application submission process can be directed to: Mina Zion, Associate Director, Corporate Collaborations,, (213) 821-6068.

Purpose: Johnson & Johnson Innovation, JLABS (JLABS) in collaboration with ETPL and Singapore-MIT Alliance for Research and Technology (SMART), have launched the Singapore QuickFire Challenge – Metabolic Disease Innovation to attract game-changing, early stage innovations that address this critical health concern. The application deadline is Wednesday, May 17, 2017.

This global competition will award the person or team(s) who submits the best idea, technology, or solution focused on metabolic disease in the following areas:

  • Therapeutics
  • Health technologies
  • Consumer healthcare
  • Medical devices
  • Diagnostics

All applicants must outline how the award will help them reach a critical milestone with the timeframe of a single year and provide a full “time-to-market” plan for their solution. Solutions need to meet the following criteria:

  • Address a metabolic disease in the Asia Pacific region
  • Integrate a novel approach within the therapeutic, device, diagnostic, consumer health and/or health technologies areas
  • Address part or all of the spectrum of prevention, interception and cure

Rewards and Benefits:

  • Up to SGD100,000 in potential grant money for winners
  • Access to ETPL laboratory space
  • One year of mentoring and support for winners from the Johnson & Johnson Innovation, ETPL and SMART staff

For more details, view the JLABS announcement.

2017 SAMSUNG Global Research Outreach Program (GRO)
Questions about the program or the application submission process can be directed to: Lawrence Lau, Associate Director, Corporate Collaborations,, (213) 821-0947.

Purpose: SAMSUNG Global Research Outreach Program (GRO) has a call for proposals focused on the following physical sciences and computer sciences research themes. The proposal deadline is Tuesday, June 6, 2017.

1. Intelligence & Recognition
2. Augmented Reality
3. Neural Processor
4. Quantum Computer
5. Next Generation Computing
6. New Device & Circuit Concept
7. Mobile/Wearable Technology
8. New Imaging
9. Metaphotonics & Photonic Sensors
10. Personal Service Robots
11. Cloud Computing
12. Security & Privacy
13. Autonomous Driving
14. Software Engineering
15. NIR Emitting Materials
16. 2D Materials & Applications
17. New QD Materials
18. High Energy Density Battery with Ultra-Safety Functions
19. Wireless Power Transmission & Energy Harvesting
20. Multi-functional Optical Films and Coatings
21. Functional Oxide
22. Material Informatics
23. AI for Analytical Science
24. Ultrafast Electron Microscopy
25. Semiconductor
26. Dielectric Materials for Next Generation Capacitor

Number of Applicants: Unlimited numbers of research proposals are permitted. All researchers are invited to apply.

Proposal Submission Process: Submission entails a non-confidential project summary, description of the project (research objectives, significance of research, research plan, milestones, and expected outcomes), and budget. The submission should be less than 10 pages.

How to Submit: Please see the 2017 GRO Proposal Guide and Format and submit your proposal through Kuali Coeus (KC), indicating the proposal’s Research Theme and Subtheme, by Tuesday, June 6, 2017.

Special Condition of the Award: USC is required to grant Samsung a commercial non-exclusive, royalty-free, paid-up license to inventions made in the awarded project. *NOTE: USC Stevens and DCG will review submitted proposals and provide feedback to the faculty prior to submitting to Samsung GRO.

Amount of Funding: Up to $100,000 per selected project per year (direct and indirect costs included), renewable up to 3 years.

USC Stevens Center for Innovation
Start-Up Investment Program

Request for Proposals currently open as of November 1, 2016. Applications accepted on a rolling basis. For full details about the program, please read: USC Stevens Start-Up Investment Program RFP Announcement.

The USC Stevens Center for Innovation aims to maximize the translation of USC research into products for public benefit. One aspect of this mission is to support the translation of research through USC Start-ups. The start-up investment program supports this effort by reducing the hurdle for raising start-up funds to pay past patent costs (patent costs incurred by USC Stevens prior to the date of the license agreement with the USC Start-up). USC Stevens will invest in USC start-ups that demonstrate strong potential for success, as assessed by expert advisors, in exchange for equity interests granted to the university. In addition, the assessment will be used to help determine the best pathway for commercialization, and to advise the faculty inventor on business strategy.


  • USC will continue to accept an equity interest in start-up companies in lieu of an upfront licensing fee whether the start-up is USC Start-up or not, when requested by the start-up.
  • Companies that qualify as USC Start-ups will have the option of applying for additional investment in the following manner:
    –Upon approval, USC will invest a portion of its patent budget in USC Start-ups that demonstrate promise to succeed as a business.
    –In exchange, USC will receive an additional minority equity stake in the USC Start-up,  providing potential for future income to expand technology transfer in lieu of patent cost reimbursement income that USC would normally receive from a licensee.
    –A decision to invest will be based on a careful assessment of the business plan for the  start-up, including analysis from outside advisors who understand the industry.
  • The USC investment will be complemented by guiding faculty to seek investments from other sources, such as Small Business Innovation Research program, angel investors, venture capital, and other sources to complement USC’s investment.

Further Information and Program Contact:
Questions about the program or the application submission process can be directed to: Michael Arciero, Director of Licensing,, (213) 821-0942.


USC Stevens Center for Innovation
Technology Advancement Grants (TAG)

Funding of up to $50,000 available. The Winter 2017 Request for Proposals submission period is now CLOSED. An announcement will be made when the next submission period opens. For full details about the program, please read: USC Stevens TAG Awards RFP Announcement.

LETTER OF INTENT (LOI) DEADLINE: 5:00 pm, Wednesday, February 1, 2017
: 5:00 pm, Friday, March 31, 2017

Technology Advancement Grants (TAGs) support early stage technologies invented at USC through validation or proof-of-concept development. The awards add value to unlicensed USC owned technology, aiming to increase the probability of obtaining a license in the future.

TAGs have a competitive two-step application process comprising an initial review by USC Stevens’ staff and a final review and recommendation by an external advisory board of industry experts. It is anticipated that part of the award may be spent on outside organizations that will work with the principal investigator and USC Stevens to further develop the technology. The external advisory board may recommend that changes be made to the Project Plan in order for the project to be eligible for funding.

Areas of Interest:

  • Technologies invented at USC in any discipline that demonstrate strong potential for commercialization through additional technology advancement investment on the scale of $50,000 or less.
  • TAG prioritizes projects that are not eligible for other USC technology advancement programs, such as the Alfred Mann Institute at USC, Coulter Program, or Ming Hsieh Institute for Research on Engineering-Medicine and Cancer.

Eligibility is limited to projects that satisfy these criteria:

  • The application must be based on Intellectual Property (IP) developed at USC with the rights assigned to USC.
  • The IP cannot be licensed, optioned, or subject to any third party rights at the time of application (other than government interests via sponsored research).
  • The principal investigator must be a USC employee eligible to serve as principal investigator, other than a term employee or visiting employee.
  • A complete invention disclosure must be on file with the USC Stevens Center for Innovation prior to the submission of the letter of intent.

Types of Assistance:
TAG Awards provide up to $50,000 for a project duration of no more than one year. Permissible expenses include:

  • Prototype development
  • Biological target validation and screening
  • Software optimization
  • Preclinical studies, such as toxicity
  • Other advanced pre-commercial research, including sub-contracts to contract research organizations.

Further Information and Program Contact:
Questions about the TAG award or the application submission process can be directed to: Michael Arciero, Director of Technology Licensing and New Ventures,, (213) 821-0942.


Allied Minds and Bristol-Myers Squibb
Deadline: Applications accepted on a rolling basis.

CATALYST is an exciting new program launched by Allied-Bristol Life Sciences (ABLS), a joint venture of global pharmaceutical company Bristol-Myers Squibb and venture builder Allied Minds, to identify and develop commercially-promising biopharmaceutical innovations from leading universities and research institutions. Launched in 2014, ABLS provides world-class expertise in drug development, access to a fully integrated drug discovery and development center (with medicinal chemistry, biological assays, animal models, pharmacology, toxicology capabilities, etc.) as well as seasoned management and the necessary financial backing to bring transformational academic discoveries to patients.

Through CATALYST, ABLS aims to:

  • Identify therapeutic opportunities with strong translational potential and that are aligned with ABLS’s strategic areas of interest.
  • License and develop lead compounds, investing ~$12M to $16M per program to undertake pre-clinical development and position the program for further clinical development and commercialization by BMS.
  • Strengthen relationships with leading academic institutions.

Disclosure and Confidentiality:
The information contained in your proposal is NOT deemed confidential unless your institution has entered into a Confidentiality Agreement with ABLS that covers the subject matter of your proposal. Please consult with Vasiliki Anest ( at USC Stevens for guidance on disclosure of confidential information.

Selection Criteria and Process:

  • Successful proposals will have elucidated novel and differentiated mechanisms, supported by strong scientific validation, underlying disease states of strategic interest (see below). Priority will be given to those projects where initial lead molecules have already been identified and possess the potential to deliver first-in class drug candidates
  • Proposals are accepted on a rolling basis. Proposals submitted by the 1st of each month are reviewed on or before the 28th of the same month. PIs of selected proposals will be invited to present their projects to the CATALYST Steering Committee. If your project is selected, we will work efficiently with you to finalize the research plan, budget, and necessary agreements.

Strategic areas of interest are:
Immuno-oncology, Oncology, Immunoscience, Cardiovascular, Genetically-defined diseases, and Fibrosis. More information on these areas of interest and the full application can be found here  

For more information, including the identification of potential background Intellectual Property, please contact Vasiliki Anest (